Vaxcyte Inc. (PCVX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Vaxcyte Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$61.46
+1.30% today
Market cap
$9.5B
Overall quality
—
Kronos AI 30-day
−5.9%
1 of 8 simulated paths end higher
Vaxcyte Inc. (PCVX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $9.5B. It trades at $61.46, up 1.30% today. 9 analysts' average target of $117.30 implies +90.9% from today's price. Kronos AI's 30-day forecast is −5.9% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $117.30 |
| Low – high | $75.00 – $163.00 |
| Analysts | 9 |
| Upside to average | +90.9% |
Kronos AI 30-day forecast
| Expected close | $57.08 (−5.9%) |
| Likely range | −10.2% … −1.9% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.